Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05025267 · ClinicalTrials.gov registry record · NA
Ability to Meet Enteral Nutritional Needs with a Peptide-based, High Protein Formula
A NA study, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT05025267 is a NA study that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 25 participants.
The verdict
NCT05025267, a NA study, has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
This is a prospective, open-label single-arm observational clinical trial to assess enteral feeding nutrition goals with a peptide-based, high protein enteral formula.
Interventions
- OTHER Medical Food: Peptide-Based Enteral Formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-01-31 |
| Est. Completion | 2023-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05025267
The ClinicalTrials.gov registry entry for NCT05025267 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Société des Produits Nestlé (SPN), which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Medical Food: Peptide-Based Enteral Formula is the first listed.
NCT05025267 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05025267 about?
NCT05025267 is a clinical study titled "Ability to Meet Enteral Nutritional Needs with a Peptide-based, High Protein Formula". This is a prospective, open-label single-arm observational clinical trial to assess enteral feeding nutrition goals with a peptide-based, high protein enteral formula.
What is the current status of trial NCT05025267?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2022-01-31. Estimated completion is 2023-05-31.
What interventions are being tested in trial NCT05025267?
The interventions under investigation include: Medical Food: Peptide-Based Enteral Formula (OTHER).
Who is sponsoring clinical trial NCT05025267?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.